In non-small cell lung cancer (NSCLC), SUMO1P3 is associated with clinical progression, and it promotes cell migration and invasion by binding and suppressing miR-136, an anti-oncogenic miRNA in human cancers [93]. The gene discussed is SUMO1P3; the disease is cancer.